Clinical Effectiveness and Safety of Vericiguat in Worsening Heart Failure with Reduced Ejection Fraction: A Single-center, Retrospective Analysis in Indian Patients
Background and Objective: In a tertiary care hospital in India, investigators evaluated the efficacy and safety of vericiguat, a new oral soluble guanylate cyclase stimulator in patients with worsening symptoms of heart failure and reduced ejection fraction (HFrEF). Methods: A retrospective assessme...
Saved in:
| Main Authors: | Pankaj Jariwala, Avvaru Guru Prakash, Poondru Rohith Reddy, Dilip Gude, Gururaj Pramod Kulkarni, Arshad Punjani, Harikishan Boorugu, Dilip Babu Madhawar, Anusha Jariwala |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Journal of the Practice of Cardiovascular Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jpcs.jpcs_63_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
by: I. V. Gribkova
Published: (2024-03-01) -
Eligible patients with heart failure prescribed vs. not prescribed vericiguat in the United States
by: Stephen J. Greene, et al.
Published: (2025-08-01) -
Decompensated heart failure: a reconceptualization in the light of updated consensus statement of the European Society of Cardiology
by: V. N. Larina, et al.
Published: (2023-12-01) -
Vericiguat improves cardiac remodelling and function in rats with doxorubicin‐induced cardiomyopathy
by: Wen Chen, et al.
Published: (2025-06-01) -
Factors contributing to transient and persistent worsening renal function in elderly patients with acute decompensated heart failure
by: Yu-qing Sun, et al.
Published: (2025-07-01)